Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC pseudoephedrine, PPA "ordinary" products subject to retail reporting threshold by DEA.

This article was originally published in The Tan Sheet

Executive Summary

OTC PSEUDOEPHEDRINE, PPA "ORDINARY" PRODUCT RETAIL REPORTING THRESHOLD established under proposed implementing regulations to the Comprehensive Methamphetamine Control Act issued by the Drug Enforcement Administration and published in the Federal Register Oct. 7. Under the 1996 law, "ordinary" pseudoephedrine or phenylpropanolamine (PPA) products were exempt from the 24 g single transaction sales reporting trigger required for non-"ordinary" products. "Ordinary" products are defined in the act as those sold in packages not exceeding 3 g pseudoephedrine or PPA base and packaged in blister packs containing no more than two dosage units per blister.
Advertisement

Related Content

Pseudoephedrine, Ephedrine Security Subject Of Upcoming DEA Rule
Pseudoephedrine, Ephedrine Security Subject Of Upcoming DEA Rule
Pseudoephedrine, Ephedrine Security Subject Of Upcoming DEA Rule

Topics

Advertisement
UsernamePublicRestriction

Register

PS087646

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel